US › Financial Services

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

US · Financial Services · Shell Companies

$10.110.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$4.3M
Profit YoY
+7411.7%
EPS
$0.07

Key statistics

Market cap
$644.0M
P/E
77.8
Forward P/E
0.0
P/B
1.31
Book value
$-0.28
EPS (TTM)
$0.13
52-week high
$10.20
52-week low
$9.86
50-day MA
$10.08
200-day MA
$10.00

Shareholding

Insiders
15.21%
Institutions
70.44%

Largest institutional holders

FundStake
Mmcap International Inc. Spc4.24%
Magnetar Financial LLC4.24%
Karpus Management Inc4.08%
Glazer Capital, LLC3.69%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND3.14%
Millennium Management LLC3.10%
Hudson Bay Capital Management LP3.09%
Wolverine Asset Management LLC2.82%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Drugs Made In America Acquisition II Corp. Ordinary Shares — free to start.

Google PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyGoldman Sachs Group IncRoyal Bank of CanadaWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-08-05.